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Africa is disproportionately burdened by communi­
cable and non­communicable diseases and their 
consequences. The 2010 ­ 2015 life expectancy at birth 
is 58.2 years for people born in Africa compared with 
77.7 years in more developed regions, with a world 
average of 70.0 years (United Nations, World Mortality Report 2013[1]). 
The Human Heredity and Health in Africa (H3Africa) Consortium 
is unique in its objective to promote human genomic research and 
health in Africa, led and managed by African investigators and their 
collaborators.[2] In line with the vision articulated in the H3Africa 
White Paper published in 2011,[3] the H3Africa Consortium aims to 
build capacity for genomic research in Africa, promote research on 
both communicable and non­communicable diseases and improve 
our understanding of the complexities of their coexistence in 
African populations, generate data and knowledge to promote an 
understanding of the health and epidemiological transition across the 
continent, and improve the health of its people. It provides a platform 
of integrated resources for biomedical research on the continent and 
is developing an extraordinary wealth of data. In addition it will host 
biorepositories with samples from over 75 000 African participants, 
many of whom have provided broad consent for sharing their data 
and samples through a managed access approach, to the benefit of the 
African and international research community.
The H3Africa initiative was born out of discussions in the African 
Society of Human Genetics and with key funders to high light the 
need to include Africans in global genomic research, and importantly 
to do so from an African perspective. In its first phase, H3Africa 
is an initiative funded and supported by the Wellcome Trust (UK) 
and the National Institutes of Health (USA). The first seven grants 
were awarded in August 2012 and the Consortium has grown to 
support 26 research groups from 27 African countries with over 
500 investigators, including a pan­African bioinformatics network, 
H3ABioNet (www.h3abionet.org), and biorepository initiatives in 
Nigeria, South Africa and Uganda. The Consortium meets every 6 
months in venues across the continent, starting in Addis Ababa in 
August 2012 and moving to Accra, Johannesburg, Cape Town, Dar es 
Salaam, Zambia, and most recently the USA (Washington DC). The 
eighth meeting is planned for Dakar in May 2016. A fair distribution 
of meetings across the breadth and length of Africa has not been 
easy, and multiple challenges have been encountered including the 
Ebola epidemic, political instability and social upheaval, reflecting 
the realities on the continent.
At its inception the H3Africa Consortium developed a series 
of working groups to meet challenges and to support its members 
through the process of developing genomic research. This was new 
territory for many of the groups and in many of the countries. 
Perhaps the most challenging and unique aspects have been in the 
ethics arena, where the research envisioned by the Consortium had 
rarely been conducted on a large scale in Africa. Although some of 
the concerns are related to inadequate funding and infrastructure, a 
challenge in all developing countries, the Consortium was sensitive 
to cultural nuances, perceptions of potential exploitation and the 
need to promote independence at institutional and national levels, 
yet aimed to balance this with sensible guidelines that ensure a 
unified set of principles and operating procedures. Internal debates 
ranged from how to ensure meaningful community engagement 
and the challenges of explaining genetics and genomics, to broad 
informed consent (defined in this context as managed but open 
access to data and biospecimens), effective engagement with ethics 
review committees and benefit sharing. To promote fairness in a 
scenario where the African partners are generally under­resourced 
and underfunded in terms of infrastructure, institutional and 
national support and lack of a critical mass of appropriately skilled 
researchers, some adaptations have been made to the usual business 
of international funding organisations.[4] These included guidelines 
stipulating that grants should be managed by the African partners, 
that projects should include strong cross­national partnerships, 
and that capacity development should be included as an important 
component. During the development of policies for data and 
biospecimen access and sharing, consideration was given to the 
length of time that the primary research producers would have for 
exclusive access, also in terms of promoting the use of the samples 
with effective African partnerships for a period of 3 years before 
they can be independently accessed through a Data and Biospecimen 
Access Committee (DBAC). Furthermore, the DBAC will consist of a 
majority of African members, but will be an independent committee 
to promote the vision of the H3Africa Consortium.
Information on the projects, the research questions they address 
and the policies and guidelines are accessible through the H3Africa 
website (www.h3africa.org). Meetings and activities are documented, 
including a record of publications associated with H3Africa, as 
well as opportunities for collaboration that are managed through 
a co­ordinating centre. The H3Africa projects range from research 
groups addressing infectious diseases, including genetic determinants 
of susceptibility to trypanosomiasis and tuberculosis, to studies on 
the microbiome in cervical cancer and in respiratory diseases. Six 
projects focus on the rise of non­communicable diseases on the 
continent, including stroke, diabetes, kidney disease, rheumatic heart 
disease, obesity and cancer. Their joint resource will include over 
50  000 African participants with significantly overlapping pheno­
typic and biomarker data enabling nested studies, meta­analyses and 
replication cohorts. One of the future goals is the expansion of studies 
into longitudinal cohorts. Two studies address neurological dis­
orders, including schizophrenia, and one examines drug susceptibility 
to tuberculosis. There is a collaborative African Genomics Network 
including investigators from Botswana and Uganda, a bioinformatics 
network (http://h3abionet.org) that includes 32 research groups 
across 15 African countries, biorepository research groups, and 
several projects addressing ethical, legal and social issues related to 
genomic research in Africa.
The success of H3Africa will be measured by knowledge 
generation, high­impact publications and the ability of its members 
to effectively access research funding for genomic research in Africa. 
Ultimately it is about developing strategies and policies towards 
reducing the burden of disease among Africans and for global health 
benefit.
For the H3Africa Consortium to realise its full potential, it requires 
additional partnerships and the support of African governments 
to promote sustained funding, maintain valuable resources and 
ensure that African investigators remain important beneficiaries of 
the Consortium. The establishment of the Alliance for Accelerating 
Excellence in Science in Africa by the African Academy of Science is 
a welcome step towards promoting African­led research aligned to 
local imperatives.[5] African investigators need to prepare themselves 
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to be strong players in the global arena of genomic research to ensure 
that those on the continent can participate fully in the next waves of 
personalised precision medicine.
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